There have been 50 recent insider transactions recorded for Intra-Cellular Therapies, Inc. (ITCI), including 9 buys and 39 sells. Total insider buying was valued at $1.35M and total insider selling at $33.64M.
Notable insiders with recent activity include Riggs Rory B, Marcus Joel S, Van Nostrand Robert L. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ITCI
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-04-02 |
Riggs Rory B |
Director |
Return of Shares |
131,512 |
$132.00 |
$17.36M |
- |
| 2025-04-02 |
Marcus Joel S |
Director |
Return of Shares |
10,000 |
$132.00 |
$1.32M |
- |
| 2025-04-02 |
Van Nostrand Robert L |
Director |
Return of Shares |
2,951 |
- |
- |
- |
| 2025-04-02 |
Halstead Michael |
President |
Return of Shares |
12,240 |
- |
- |
- |
| 2025-04-02 |
Mates Sharon |
Chairman and CEO |
Return of Shares |
34,970 |
- |
- |
- |
| 2025-04-02 |
Neumann Mark |
EVP, Chief Commercial Officer |
Return of Shares |
17,916 |
$56.73 |
$1.02M |
- |
| 2025-04-02 |
Narula Sanjeev |
Executive Vice President & CFO |
Return of Shares |
22,727 |
- |
- |
- |
| 2025-04-02 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
Return of Shares |
53,967 |
$12.73 |
$687K |
- |
| 2025-04-02 |
Salas Eduardo Rene |
Director |
Return of Shares |
1,567 |
$132.00 |
$206.84K |
- |
| 2025-03-26 |
Mates Sharon |
Chairman and CEO |
Gift (Received) |
190,000 |
- |
- |
190,000 |
| 2025-03-10 |
Halstead Michael |
President |
Option Exercise (Sell) |
7,345 |
- |
- |
- |
| 2025-03-10 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
20,566 |
- |
- |
- |
| 2025-03-10 |
Neumann Mark |
EVP, Chief Commercial Officer |
Option Exercise (Sell) |
7,345 |
- |
- |
- |
| 2025-03-10 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
Option Exercise (Sell) |
7,345 |
- |
- |
- |
| 2025-03-06 |
Halstead Michael |
President |
Option Exercise (Sell) |
13,133 |
- |
- |
13,133 |
| 2025-03-06 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
40,712 |
- |
- |
40,713 |
| 2025-03-06 |
Neumann Mark |
EVP, Chief Commercial Officer |
Option Exercise (Sell) |
13,133 |
- |
- |
13,133 |
| 2025-03-06 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
Option Exercise (Sell) |
13,133 |
- |
- |
13,133 |
| 2025-03-01 |
Halstead Michael |
President |
Tax Withholding of RSU |
6,261 |
$128.20 |
$802.66K |
11,304 |
| 2025-03-01 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
34,969 |
- |
- |
69,940 |
| 2025-03-01 |
Neumann Mark |
EVP, Chief Commercial Officer |
Option Exercise (Sell) |
8,742 |
- |
- |
17,485 |
| 2025-03-01 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
Option Exercise (Sell) |
8,742 |
- |
- |
17,485 |
| 2025-02-24 |
Marcus Joel S |
Director |
Option Exercise (Sell) |
7,009 |
$63.79 |
$447.1K |
- |
| 2025-02-03 |
Halstead Michael |
President |
RSU Award |
45,454 |
- |
- |
45,454 |
| 2025-02-03 |
Mates Sharon |
Chairman and CEO |
RSU Award |
121,212 |
- |
- |
121,212 |
| 2025-02-03 |
Neumann Mark |
EVP, Chief Commercial Officer |
RSU Award |
22,727 |
- |
- |
22,727 |
| 2025-02-03 |
Narula Sanjeev |
Executive Vice President & CFO |
RSU Award |
22,727 |
- |
- |
22,727 |
| 2025-02-03 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
RSU Award |
24,621 |
- |
- |
24,621 |
| 2025-01-31 |
Halstead Michael |
President |
Tax Withholding of RSU |
5,691 |
$127.00 |
$722.76K |
5,326 |
| 2025-01-31 |
Mates Sharon |
Chairman and CEO |
Tax Withholding of RSU |
15,233 |
$127.00 |
$1.93M |
1,085,943 |
| 2025-01-31 |
Neumann Mark |
EVP, Chief Commercial Officer |
Tax Withholding of RSU |
4,729 |
$127.00 |
$600.58K |
35,988 |
| 2025-01-31 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
Tax Withholding of RSU |
4,730 |
$127.00 |
$600.71K |
26,090 |
| 2024-12-31 |
Riggs Rory B |
Director |
RSU Award |
215 |
$83.52 |
$17.96K |
131,512 |
| 2024-12-05 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
51,697 |
$12.73 |
$658.1K |
- |
| 2024-12-04 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
51,000 |
$12.73 |
$649.23K |
51,697 |
| 2024-11-13 |
Halstead Michael |
President |
Option Exercise (Sell) |
18,714 |
$36.89 |
$690.36K |
- |
| 2024-11-12 |
Halstead Michael |
President |
Option Exercise (Sell) |
22,869 |
$23.94 |
$547.48K |
- |
| 2024-09-30 |
Riggs Rory B |
Director |
RSU Award |
246 |
$73.17 |
$18K |
117,108 |
| 2024-08-30 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
34,396 |
$12.73 |
$437.86K |
102,697 |
| 2024-08-29 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
35,604 |
$12.73 |
$453.24K |
137,093 |
| 2024-08-28 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
32,699 |
$17.57 |
$574.52K |
- |
| 2024-08-27 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
40,513 |
$17.57 |
$711.81K |
32,699 |
| 2024-08-26 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
22,713 |
$17.57 |
$399.07K |
73,212 |
| 2024-08-23 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
28,680 |
$17.57 |
$503.91K |
95,925 |
| 2024-08-22 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
39,380 |
$17.57 |
$691.91K |
124,605 |
| 2024-08-21 |
Mates Sharon |
Chairman and CEO |
Option Exercise (Sell) |
53,013 |
$17.57 |
$931.44K |
163,985 |
| 2024-08-16 |
Neumann Mark |
EVP, Chief Commercial Officer |
Option Exercise (Sell) |
18,714 |
$36.89 |
$690.36K |
- |
| 2024-08-12 |
Narula Sanjeev |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-08-12 |
Narula Sanjeev |
Executive Vice President & CFO |
RSU Award |
17,251 |
$74.90 |
$1.29M |
17,251 |
| 2024-06-28 |
Riggs Rory B |
Director |
RSU Award |
262 |
$68.49 |
$17.94K |
116,862 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
